Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 14,534,880 | $24,563,948 | 1.55% | |
| 2. | Vestal Point Capital Ryan Wilder | 843,461 | $1,425,449 | -3% | 0.03% |
| 3. | Hudson Bay Capital Management Sander Gerber | 717,982 | $1,213,390 | 0% | |
| 4. | Pentwater Capital Management Matthew Halbower | 600,000 | $1,014,000 | 0.01% | |
| 5. | Citadel Investment Group Ken Griffin | 80,195 | $135,530 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 962,524 | $1,658,210 | 0% | |
| 2. | 904,895 | $1,563,837 | 0.11% | |
| 3. | 921,500 | $1,557,335 | 0% | |
| 4. | 828,803 | $1,400,677 | 0.32% | |
| 5. | 522,057 | $882,276 | 0.43% |